GLTO- Galecto, Inc.

Name: Galecto, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Galecto, Inc. (GLTO) has 12 insiders with recent SEC Form 4 filings, including 4 buys and 33 sells. GLTO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Fairmount Funds Management LLC	5.81M	$166.66M	-
Other	Hewes L. Becker	264.6K	$7.59M	-
Dir	Bruno Julianne	137.0K	$3.93M	-
CEO	Schambye Hans T.	5.4K	$154.4K	-
Other	Winslow Garrett	2.1K	$60.5K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 31, 2023	Orbimed Advisors LLC67	10% Owner	Sell	209,400	$3.00	$628,200.00	-6.3%	-82.6%	-81.8%
Jul 25, 2023	Orbimed Advisors LLC67	10% Owner	Sell	39,200	$2.92	$114,464.00	-1.2%	-81.3%	-81.8%
Jul 13, 2023	Orbimed Advisors LLC67	10% Owner	Sell	194,700	$2.40	$467,280.00	-5.5%	-72.9%	-78.0%
Apr 17, 2023	Orbimed Advisors LLC67	10% Owner	Sell	68,481	$1.87	$128,256.61	-0.6%	+11.6%	-66.8%
Apr 12, 2023	Orbimed Advisors LLC67	10% Owner	Sell	67,537	$1.80	$121,356.87	-0.6%	+42.5%	-60.9%
Apr 6, 2023	Orbimed Advisors LLC67	10% Owner	Sell	102,630	$2.16	$221,993.70	-1.4%	+37.4%	-60.0%
Mar 22, 2022	Lindmark Bertil	Chief Medical Officer	Buy	14,604	$2.16	$31,544.64	+730.2%	-18.7%	-11.9%
Mar 22, 2022	Schambye Hans T.	Chief Executive Officer	Buy	5,000	$2.15	$10,750.00	+10.5%	-18.7%	-11.9%
Dec 3, 2021	Winslow Garrett	General Counsel	Buy	2,000	$2.48	$4,960.00	+100.0%	-25.4%	-37.1%
Dec 3, 2021	Freve Jonathan	Chief Financial Officer	Buy	4,000	$2.49	$9,960.00	+50.0%	-25.4%	-37.1%

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC